FDA Inspection
Trifarma S.p.A.Trifarma S.p.A. – FDA Inspection, Jan 27, 2017
Record Details
This FDA Inspection record concerns Trifarma S.p.A., with an inspection on January 27, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · cbf49105-8cf3-4df8-ada8-c24df5a1b33f
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1013013
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Trifarma S.p.A.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| September 27, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 28, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 27, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 29, 2014 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 28, 2010 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Trifarma S.p.A.
- FDA Inspection 1289850 - 2024-09-27
- FDA Inspection 1100281 - 2019-02-28
- FDA Inspection 924404 - 2015-02-27
- FDA Inspection 866279 - 2014-01-29
- FDA Inspection 650163 - 2010-01-28
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.